Dermatopathological challenges in the human immunodeficiency virus and acquired immunodeficiency syndrome era

Histopathology

Volumn 56, Issue 1, 2010, Pages 39-56

  Ramdial, Pratistadevi K ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

AIDS; Dermatopathological; HAART; HIV; Infections; Kaposi sarcoma; Skin

Indexed keywords

ABACAVIR; AMPRENAVIR; ATAZANAVIR; COTRIMOXAZOLE; DARUNAVIR; DELAVIRDINE; DIDANOSINE; EFAVIRENZ; EMTRICITABINE; ENFUVIRTIDE; ETRAVIRINE; FOSAMPRENAVIR; INDINAVIR; LOPINAVIR; MARAVIROC; NEVIRAPINE; RITONAVIR; TENOFOVIR; TIPRANAVIR; ZIDOVUDINE;

ACNE; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS; ALOPECIA; ANGIOLIPOMA; BACTERIUM CULTURE; COMORBIDITY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CUTANEOUS T CELL LYMPHOMA; CYTOMEGALOVIRUS; DESQUAMATION; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG ERUPTION; DRUG INDUCED DISEASE; ECZEMA; EOSINOPHILIA; ERYTHEMA MULTIFORME; EXFOLIATIVE DERMATITIS; FUNGUS CULTURE; FURUNCULOSIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HISTOPLASMA CAPSULATUM; HIV ASSOCIATED LIPODYSTROPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERPIGMENTATION; HYPERSENSITIVITY; HYPERTRICHOSIS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOHISTOCHEMISTRY; INJECTION SITE ERYTHEMA; INJECTION SITE INDURATION; INJECTION SITE NODULE; KAPOSI SARCOMA; LARGE CELL LYMPHOMA; LEIOMYOMA; LEIOMYOSARCOMA; MACULOPAPULAR RASH; MEASLES LIKE RASH; MYCOBACTERIUM TUBERCULOSIS; MYCOSIS FUNGOIDES; NAIL COLOR DEFECT; NONHODGKIN LYMPHOMA; PAPULAR URTICARIA; PARONYCHIA; PLASMA CELL GRANULOMA; PRIORITY JOURNAL; PRURITUS; PSEUDOLYMPHOMA; REVIEW; SARCOIDOSIS; SKIN DEFECT; SKIN LEISHMANIASIS; SKIN LYMPHOMA; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; TUBERCULOSIS; URTICARIA; XEROSIS;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV; HIV INFECTIONS; HUMANS; SKIN DISEASES;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 73449135493     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2009.03456.x     Document Type: Review

References (71)

1. Bartlett JG. Tuberculosis and HIV infection: partners in human tragedy. J. Infect. Dis. 2007 196 S124 S125.
2. Sing Y, Ramdial PK. Cryptococcal inflammatory pseudotumors. Am. J. Surg. Pathol. 2007 31 1521 1527.
3. Ware AJ, Cockerell CJ, Skiest DJ, Kussman HM. Disseminated sporotrichosis with extensive cutaneous involvement in a patient with AIDS. J. Am. Acad. Dermatol. 1999 40 350 355.
4. Eidbo J, Sanchez RL, Tschen JA, Ellner KM. Cutaneous manifestations of histoplasmosis in the acquired immune deficiency syndrome. Am. J. Surg. Pathol. 1993 17 110 116.
5. Ramdial PK, Mosam A, Dlova NC et al. Disseminated cutaneous histoplasmosis in patients infected with human immunodeficiency virus. J. Cutan. Pathol. 2002 29 215 225.
6. González-Beato MJ, Moyano B, Sanchez C et al. Kaposi's sarcoma-like lesions and other nodules as cutaneous involvement in AIDS-related visceral leishmaniasis. Br. J. Dermatol. 2000 143 1316 1318.
7. Castellano VM, Rodríguez-Peralto JL, Alonso S, Gómez-De la Fuente E, Ibarrola C. Dermatofibroma parasitised by Leishmania in HIV infection: A new morphologic expression of dermal Kala Azar in an immunodepressed patient. J. Cutan. Pathol. 1999 26 516 519.
8. Forsyth SF, Lawn SD, Miller RF et al. Multiple dermatofibroma-like lesions in a human immunodeficiency virus-positive patient coinfected with visceral leishmaniasis. Br. J. Dermatol. 2003 148 171 192.
9. Barlow RJ, Schulz EJ. Necrotising folliculitis in AIDS-related complex. Br. J. Dermatol. 1987 116 581 584.
10. Eisman S. Pruritic papular eruption in HIV. Dermatol. Clin. 2006 24 449 457.
11. Cole MC, Cohen PR, Satra KH, Grossman ME. The concurrent presence of systemic disease pathogens and cutaneous Kaposi's sarcoma in the same lesion: Histoplasma capsulatum and Kaposi's sarcoma coexisting in a single skin lesion in patient with AIDS. J. Am. Acad. Dermatol. 1992 26 285 287.
12. Kempf W, Adams V, Pfaltz M et al. Human herpesvirus type 6 and cytomegalovirus in AIDS-associated Kaposi's sarcoma: no evidence for an etiological association. Hum. Pathol. 1995 26 914 919.
13. Meer S, Altini M. Cytomegalovirus co-infection in AIDS-associated oral Kaposi's sarcoma. Adv. Dent. Res. 2006 19 96 98.
14. Bournerias I, Boisnic S, Patey O et al. Unusual cutaneous cytomegalovirus involvement in patients with acquired immunodeficiency syndrome. Arch. Dermatol. 1989 125 1243 1246.
15. Chaudhary M, Kulkarni M. Molluscum contagiosum in human immunodeficiency virus infected patients. Inf. J. Dent. Res. 2008 19 155 159.
16. Cribier B, Scrivener Y, Grosshans E. Molluscum contagiosum: histologic patterns and associated lesions. Am. J. Dermatopathol. 2001 23 99 103.
17. Gur I. The epidemiology of molluscum contagiosum in HIV seropositive patients: a unique entity or insignificant finding? Int. J. STD AIDS 2008 19 503 506.
18. Logani S, Lucas DR, Cheng JD, Ioachim HL, Adsay NV. Spindle cell tumors associated with mycobacteria in lymph nodes of HIV-positive patients: 'Kaposi sarcoma with mycobacteria' and 'mycobacterial pseudotumor'. Am. J. Surg. Pathol. 1999 23 656 661.
19. Kandemir NO, Yurdakan GG, Bektas S. Classic Kaposi sarcoma with sarcoid-like granulomas: a case report and review of the literature. Histopathology 2008 53 (Suppl. 1 1 432.
20. Lanjewar D. Co-existent lymphoma with tuberculosis and Kaposi's sarcoma with tuberculosis occurring in lymph node in patient with aids: report of two cases. Histopathology 2008 5353 (Suppl. 1 1 432.
21. Kuruvilla A, Humphrey DM, Emko P. Coexistent oral cryptococcosis and Kaposi's sarcoma in acquired immunodeficiency syndrome. Cutis 1992 49 260 264.
22. Murdoch DM, Venter WD, Van Rie A, Feldman C. Immune reconstitution inflammatory syndrome (IRIS): a review of common infectious manifestations and treatment options. AIDS Res. Ther. 2007 4 9.
23. Shelburne SA, Montes M, Hamill RJ. Immune reconstitution inflammatory syndrome: more answers, more questions. J. Antimicrob. Chemother. 2006 57 167 170.
24. Luther J, Glesby MJ. Dermatologic adverse effects of antiretroviral therapy. Am. J. Clin. Dermatol. 2007 8 221 233.
25. Gupta S, Mathur P, Maskey D, Wig N, Singh S. Immune restoration syndrome with disseminated Penicillium marneffei and cytomegalovirus co-infections in an AIDS patient. AIDS Res. Ther. 2007 4 21.
26. Couppié P, Abel S, Voinchet H et al. Immune reconstitution inflammatory syndrome associated with HIV and leprosy. Arch. Dermatol. 2004 140 997 1000.
27. Mirmirani P, Maurer TA, Herndier B et al. Sarcoidosis in a patient with AIDS: a manifestation of immune restoration syndrome. J. Am. Acad. Dermatol. 1999 41 285 286.
28. Gomez V, Smith PR, Burack J, Daley R, Rosa U. Sarcoidosis after antiretroviral therapy in a patient with acquired immunodeficiency syndrome. Clin. Infect. Dis. 2000 31 1278 1280.
29. Blanche P, Passeron A, Gombert B et al. Sarcoidosis and HIV infection: influence of highly active antiretroviral therapy. Br. J. Dermatol. 1999 140 1169 1199.
30. Li N, Bajoghli A, Kubba A, Bhawan J. Identification of mycobacterial DNA in cutaneous lesions of sarcoidosis. J. Cutan. Pathol. 1999 26 271 278.
31. Fernández-Casado A, Martin-Ezquerra G, Yébenes M et al. Progressive supravenous granulomatous nodular eruption in a human immunodeficiency virus-positive intravenous drug user treated with highly active antiretroviral therapy. Br. J. Dermatol. 2008 158 145 149.
32. Farrant P, Higgins E. A granulomatous response to tribal medicine as a feature of the immune reconstitution syndrome. Clin. Exp. Dermatol. 2004 29 366 368.
33. Sinha S, Fernández G, Kapila R, Lambert WC, Schwartz RA. Diffuse cutaneous leishmaniasis associated with the immune reconstitution inflammatory syndrome. Int. J. Dermatol. 2008 47 1263 1270.
34. Desjeux P, Alvar J. Leishmania/HIV co-infections: epidemiology in Europe. Ann. Trop. Med. Parasitol. 2003 97 S3 S15.
35. Olivier M, Badaro R, Medrano FJ et al. The pathogenesis of leishmania/HIV coinfections: cellular and immunological mechanisms. Ann. Trop. Med. Parasitol. 2003 97 S79 S98.
36. Agudelo SP, Restrepo S, Velez ID. Cutaneous new world leishmaniasis-sporotrichosis co-infection: report of three cases. J. Am. Acad. Dermatol. 1999 40 1002 1004.
37. Lawn SD, Wood C, Lockwood DN. Borderline tuberculoid leprosy: an immune reconstitution phenomenon in a human immunodeficiency virus-infected person. Clin. Infect. Dis. 2003 36 e5 e6.
38. Ustianowski AP, Lawn SD, Lockwood DN. Interactions between HIV infection and leprosy: a paradox. Lancet Infect. Dis. 2006 6 350 360.
39. Singal A, Mehta S, Pandhi D. Immune reconstitution inflammatory syndrome in an HIV seropositive leprosy patient. Lepr. Rev. 2006 77 76 80.
40. Kharkar V, Bhor UH, Mahajan S, Khopkar U. Type I lepra reaction presenting as immune reconstitution inflammatory syndrome. Indian J. Dermatol. Venereol. Leprol. 2007 73 253 256.
41. Breton G, Adle-Biassette H, Therby A et al. Immune reconstitution inflammatory syndrome in HIV-infected patients with disseminated histoplasmosis. AIDS 2006 20 119 132.
42. Yudin MH, Kaul R. Progressive hypertrophic genital herpes in an HIV-infected woman despite immune recovery on antiretroviral therapy. Infect. Dis. Obstet. Gynecol. 2008 2008 592532.
43. Qazi NA, Morlese JF, Walsh JC et al. Severe cutaneous ulceration secondary to cytomegalovirus inclusion disease during successful immune reconstitution with HAART. AIDS Read 2002 12 452-454, 456 457.
44. Leidner RS, Aboulafia DM. Recrudescent Kaposi's sarcoma after initiation of HAART: a manifestation of immune reconstitution syndrome. AIDS Patient Care STDs 2005 19 635 644.
45. Weir A, Wansbrough-Jones M. Mucosal Kaposi's sarcoma following protease inhibitor therapy in an HIV-infected patient. AIDS 1997 11 1895 1896.
46. Eliaszewicz M, Flahault A, Roujeau JC et al. Prospective evaluation of risk factors of cutaneous drug reactions to sulfonamides in patients with AIDS. J. Am. Acad. Dermatol. 2002 47 40 46.
47. Rotunda A, Hirsch RJ, Scheinfeld N, Weinberg JM. Severe cutaneous reactions associated with the use of human immunodeficiency virus medications. Acta Derm. Venereol. 2003 83 1 9.
48. Kong HH, Myers SA. Cutaneous effects of highly active antiretroviral therapy in HIV-infected patients. Dermatol. Ther. 2005 18 58 66.
49. Ward HA, Russo GG, Shrum J. Cutaneous manifestations of antiretroviral therapy. J. Am. Acad. Dermatol. 2002 46 284 293.
50. Smith KJ, Skelton HG, Yeager J et al. Increased drug reactions in HIV-1-positive patients: a possible explanation based on patterns of immune dysregulation seen in HIV1 disease. Clin. Exp. Dermatol. 1997 22 118 123.
51. Ball RA, Kinchelow T. Injection site reactions with HIV-1 fusion inhibitor enfuvirtide. J. Am. Acad. Dermatol. 2003 49 826 831.
52. Eng W, Cockerell CJ. Histological features of Kaposi sarcoma in a patient receiving highly active antiviral therapy. Am. J. Dermatopathol. 2004 26 127 132.
53. Krischer J, Rutschmann O, Hirschel B et al. Regression of Kaposi's sarcoma during therapy with HIV-1 protease inhibitors: a prospective pilot study. J. Am. Acad. Dermatol. 1998 38 594 598.
54. Pantanowitz L, Dezube BJ, Pinkus GS, Tahan SR. Histological characterization of regression in acquired immunodeficiency syndrome-related Kaposi's sarcoma. J. Cutan. Pathol. 2004 31 26 34.
55. Calonje E. Vascular tumours: tumors and tumor-like conditions of blood vessels and lymphatics. In Elder DE, Elenitsas RE, Johnson BL, Murphy GF, Xu X eds. s. Lever's histopathology of the ski. Philadelphia : Lippincott Williams & Wilkins, 2009 1007 1056.
56. Urquhart JL, Uzieblo A, Kohler S. Detection of HHV-8 in pyogenic granuloma-like Kaposi sarcoma. Am. J. Dermatopathol. 2006 28 317 321.
57. Hengge UR, Stocks K, Goos M. Acquired immune deficiency syndrome-related hyperkeratotic Kaposi's sarcoma with severe lymphoedema: report of five cases. Br. J. Dermatol. 2000 142 501 505.
58. Cheuk W, Li PCK, Chan JKC. Epstein-Barr virus-associated smooth muscle tumour: a distinctive mesenchymal tumour of immunocompromised individuals. Pathology 2002 34 245 249.
59. Deyrup AT, Lee VK, Hill CE et al. Epstein-Barr virus-associated smooth muscle tumors are distinctive mesenchymal tumors reflecting multiple infection events. A clinicopathologic and molecular analysis of 29 tumors from 19 patients. Am. J. Surg. Pathol. 2006 30 75 82.
60. Orlow SJ, Kamino H, Lawrence RL. Multiple subcutaneous leiomyosarcomas in an adolescent with AIDS. Am. J. Pediatr. Hematol. Oncol. 1992 14 265 268.
61. Weiss SW. Smooth muscle tumors of soft tissue. Adv. Anat. Pathol. 2002 9 351 359.
62. Cooley TP. Non-AIDS-defining cancer in HIV-infected people. Hematol. Oncol. Clin. North Am. 2003 17 889 899.
63. Wilkins K, Turner R, Dolev JC et al. Cutaneous malignancy and human immunodeficiency virus disease. J. Am. Acad. Dermatol. 2006 54 189 206.
64. Robertson P, Scadden DT. Immune reconstitution in HIV and its relationship to cancer. Hematol. Oncol. Clin. North Am. 2003 17 703 716.
65. Beylot-Barry M, Vergier B, Masquelier B et al. The spectrum of cutaneous lymphomas in HIV infection. A study of 21 cases. Am. J. Surg. Pathol. 1999 23 1208 1216. (Pubitemid 29474590)
66. Friedler S, Parisi MT, Waldo E et al. Atypical cutaneous lymphoproliferative disorder in patients with HIV infection. Int. J. Dermatol. 1999 38 111 118.
67. + T cell infiltrates in advanced HIV infection. J. Am. Acad. Dermatol. 1999 41 722 727.
68. Schartz NEC, De La Blanchardiére A, Alaoui S et al. Regression of CD8+ pseudolymphoma after HIV antiviral triple therapy. J. Am. Acad. Dermatol. 2003 49 139 141.
69. Jambusaria A, Shafer D, Wu H, Al-Saleem T, Perlis C. Cutaneous plasmablastic lymphoma. J. Am. Acad. Dermatol. 2008 58 676 678.
70. Bernabeu-Wittel J, Gonzalo DH, Luque R, Borrero JJ, Conejo-Mir J. Cutaneous nodules as diagnostic key of an extraoral plasmablastic lymphoma in an human immunodeficiency virus-infected patient. J. Eur. Acad. Dermatol. Venereol. 2008 22 101 138.
71. Gilaberte M, Gallardo F, Bellosillo B et al. Recurrent and self-healing cutaneous monoclonal plasmablastic infiltrates in a patient with AIDS and Kaposi sarcoma. Br. J. Dermatol. 2005 153 828 832.